EP2999711

Fjölmýxínafleiður og notkun þeirra í samsetta meðferð ásamt mismunandi sýklalyfjum

  • Status:
    EP einkaleyfi í gildi á Íslandi
  • EP appl. date:
    21.5.2014
  • EP published:
    29.6.2022
  • EP application number:
    14726731.4
  • Max expiry date:
    20.5.2034
  • Expiry date:
    20.5.2026
  • Next due date:
    31.5.2026
  • Title in English:
    POLYMYXIN DERIVATIVES AND THEIR USE IN COMBINATION THERAPY TOGETHER WITH DIFFERENT ANTIBIOTICS
  • Language of the patent:
    English

Timeline

Today
21.5.2014EP application
29.6.2022EP Publication
8.8.2022Translation submitted
15.9.2022Registration published
20.5.2026Expires

Owner

  • Name:
    Spero Therapeutics, Inc.
  • Address:
    675 Massachusetts Avenue, 14th Floor, Cambridge, MA 02139, US

Inventor

  • Name:
    BROWN, Pamela
  • Address:
    Reading Berkshire RG1 8LS, GB
  • Name:
    DAWSON, Michael
  • Address:
    Reading Berkshire RG1 8LS, GB
  • Name:
    SIMONOVIC, Mona
  • Address:
    Reading Berkshire RG1 8LS, GB
  • Name:
    BOAKES, Steven
  • Address:
    Reading Berkshire RG1 8LS, GB
  • Name:
    DUPERCHY, Esther
  • Address:
    Reading Berkshire RG1 8LS, GB

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113, Reykjavík,

Priority

  • Number:
    201309248
  • Date:
    22.5.2013
  • Country:
    GB
  • Number:
    201404301
  • Date:
    11.3.2014
  • Country:
    GB

Classification

  • Categories:
    C07K 7/62, A61K 38/12

Annual fees

Number

Paid

Expires

Payer

Number: 10

Paid: 2.3.2023

Expires: 20.5.2024

Payer: Árnason Faktor ehf.

Number: 11

Paid: 12.4.2024

Expires: 20.5.2025

Payer: Árnason Faktor ehf.

Number: 12

Paid: 5.5.2025

Expires: 20.5.2026

Payer: Árnason Faktor ehf.

Upload documents